{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:13:38Z","timestamp":1772766818280,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ad.2017.07.002","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T04:30:37Z","timestamp":1502944237000},"page":"911-917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Psoriasis moderada. Propuesta de definici\u00f3n"],"prefix":"10.1016","volume":"108","author":[{"given":"M.","family":"Llamas-Velasco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"de la Cueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Notario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mart\u00ednez-Pilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Martorell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Moreno-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2017.07.002_bib0105","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ad.2013.12.008","article-title":"Prevalencia de la psoriasis en Espa\u00f1a en la era de los agentes biol\u00f3gicos","volume":"105","author":"Ferr\u00e1ndiz","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2017.07.002_bib0110","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaad.2008.01.006","article-title":"National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening","volume":"58","author":"Kimball","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2017.07.002_bib0115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0001-7310(09)70821-X","article-title":"Documento de consenso sobre la evaluaci\u00f3n y el tratamiento de la psoriasis moderada\/grave del Grupo Espa\u00f1ol de Psoriasis de la Academia Espa\u00f1ola de Dermatolog\u00eda y Venereolog\u00eda","volume":"100","author":"Puig","year":"2009","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2017.07.002_bib0120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","article-title":"Psoriasis causes as much disability as other major medical diseases","volume":"41","author":"Rapp","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2017.07.002_bib0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7525-4-35","article-title":"Quality of life in patients with psoriasis","volume":"4","author":"Bhosle","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ad.2017.07.002_bib0130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1157\/13099796","article-title":"Impacto de la psoriasis en la calidad de vida relacionada con la salud","volume":"128","author":"Ferr\u00e1ndiz Foraster","year":"2007","journal-title":"Med Clin (Barc)"},{"issue":"Suppl 2","key":"10.1016\/j.ad.2017.07.002_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jdv.13542","article-title":"Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology","volume":"30","author":"Daud\u00e9n","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2017.07.002_bib0140","unstructured":"Committee for medical producs for human use of EMEA. Guideline on clinical investigation of medicinal products indicated for the treatment of psoriasis. European Medicines Agency Evaluation of Medicines for Human Use, EMEA\/CHMP\/EWP\/2454\/02 [consultado 10 Agos 2015]. Disponible en: http:\/\/www.ema.europa.eu\/."},{"key":"10.1016\/j.ad.2017.07.002_bib0145","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2133.2006.07405.x","article-title":"EUROPSO. European patient perspectives on the impact of psoriasis: The EUROPSO patient membership survey. Patient Survey Group","volume":"155","author":"Dubertret","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2017.07.002_bib0150","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000111511","article-title":"What characterizes the severity of psoriasis? Results from an epidemiological study of over 3,300 patients in the Iberian region","volume":"216","author":"Garc\u00eda-Diez","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2017.07.002_bib0155","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1610-0387.2008.06807.x","article-title":"Quality of psoriasis care in Germany--results of the national study PsoHealth 2007","volume":"6","author":"Augustin","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ad.2017.07.002_bib0160","first-page":"603","article-title":"Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis--a retrospective study (FUTURE)","volume":"7","author":"Reich","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ad.2017.07.002_bib0165","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2133.2009.09505.x","article-title":"British Association of Dermatologists\u2019 guidelines for biologic interventions for psoriasis 2009","volume":"161","author":"Smith","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2017.07.002_bib0170","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.clindermatol.2009.03.001","article-title":"Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI pass\u00e9? Facts and controversies","volume":"28","author":"Naldi","year":"2010","journal-title":"Clinics in Dermatology"},{"key":"10.1016\/j.ad.2017.07.002_bib0175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaad.2010.11.055","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions","volume":"65","author":"Menter","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2017.07.002_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","article-title":"Definition of treatment goals for moderate to severe psoriasis: A European consensus","volume":"303","author":"Mrowietz","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ad.2017.07.002_bib0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.det.2011.08.012","article-title":"A review of health outcomes in patients with psoriasis","volume":"30","author":"Li","year":"2012","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ad.2017.07.002_bib0190","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2017.07.002_bib0195","unstructured":"Flor-Garc\u00eda A, Mart\u00ednez-Valdivieso L, Ortiz-Navarro MR. Informe t\u00e9cnico de terapias biol\u00f3gicas en dermatolog\u00eda: artritis psori\u00e1sica y psoriasis. Servicio de Salud de Castilla la Mancha, mayo de 2012 [consultado 10 Oct 2015]. Disponible en: http:\/\/sescam.castillalamancha.es\/."},{"key":"10.1016\/j.ad.2017.07.002_bib0200","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3122\/jabfm.2013.06.130055","article-title":"Psoriasis vulgaris: An evidence-based guide for primary care","volume":"26","author":"Kupetsky","year":"2013","journal-title":"J Am Board Fam Med"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731017303769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731017303769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:06:44Z","timestamp":1757552804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731017303769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0001731017303769"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2017.07.002","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis moderada. Propuesta de definici\u00f3n","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2017.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 AEDV. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}